Catherine E. Owen Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

AGIO Quotes by TradingView

Catherine E. Owen is Director of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 6,073 shares of AGIO, which is worth approximately $237,272. The most recent transaction as insider was on Jun 20, 2025, when has been sold 2,120 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.07K
207.34% 3M change
207.34% 12M change
Total Value Held $237,272

Catherine E. Owen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2025
BUY
Exercise of conversion of derivative security
-
2,120 Added 25.88%
6,073 Common Stock
Jun 13 2025
BUY
Exercise of conversion of derivative security
-
1,977 Added 33.34%
3,953 Common Stock
Jun 13 2024
BUY
Exercise of conversion of derivative security
-
1,976 Added 50.0%
1,976 Common Stock

Also insider at

ACAD
ACADIA PHARMACEUTICALS INC Healthcare
Chief Executive Officer
OPTN
OptiNose, Inc. Healthcare
Director
CEO

Catherine E. Owen

Director
Yardley, PA

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGIO